| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
6e-17 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-08 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-07 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |